Correlation Between Revolution Medicines, and Unilever PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines, and Unilever PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines, and Unilever PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines, Warrant and Unilever PLC ADR, you can compare the effects of market volatilities on Revolution Medicines, and Unilever PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines, with a short position of Unilever PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines, and Unilever PLC.

Diversification Opportunities for Revolution Medicines, and Unilever PLC

-0.83
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Revolution and Unilever is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines, Warrant and Unilever PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unilever PLC ADR and Revolution Medicines, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines, Warrant are associated (or correlated) with Unilever PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unilever PLC ADR has no effect on the direction of Revolution Medicines, i.e., Revolution Medicines, and Unilever PLC go up and down completely randomly.

Pair Corralation between Revolution Medicines, and Unilever PLC

Assuming the 90 days horizon Revolution Medicines, Warrant is expected to generate 71.26 times more return on investment than Unilever PLC. However, Revolution Medicines, is 71.26 times more volatile than Unilever PLC ADR. It trades about 0.08 of its potential returns per unit of risk. Unilever PLC ADR is currently generating about 0.05 per unit of risk. If you would invest  0.00  in Revolution Medicines, Warrant on September 2, 2024 and sell it today you would earn a total of  36.00  from holding Revolution Medicines, Warrant or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy47.78%
ValuesDaily Returns

Revolution Medicines, Warrant  vs.  Unilever PLC ADR

 Performance 
       Timeline  
Revolution Medicines, 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines, Warrant are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Revolution Medicines, showed solid returns over the last few months and may actually be approaching a breakup point.
Unilever PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Unilever PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's essential indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Revolution Medicines, and Unilever PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Revolution Medicines, and Unilever PLC

The main advantage of trading using opposite Revolution Medicines, and Unilever PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines, position performs unexpectedly, Unilever PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unilever PLC will offset losses from the drop in Unilever PLC's long position.
The idea behind Revolution Medicines, Warrant and Unilever PLC ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope